Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-25-022615
Filing Date
2025-03-11
Accepted
2025-03-11 17:17:03
Documents
17
Period of Report
2025-03-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm258886d1_8ka.htm   iXBRL 8-K/A 30139
2 EXHIBIT 99.1 tm258886d1_ex99-1.htm EX-99.1 39065
3 EXHIBIT 99.2 tm258886d1_ex99-2.htm EX-99.2 29537
7 GRAPHIC tm258886d1_ex99-1img001.jpg GRAPHIC 17492
8 GRAPHIC tm258886d1_ex99-2img001.jpg GRAPHIC 18027
  Complete submission text file 0001104659-25-022615.txt   342779

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ptgx-20250308.xsd EX-101.SCH 3036
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptgx-20250308_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptgx-20250308_pre.xml EX-101.PRE 22373
19 EXTRACTED XBRL INSTANCE DOCUMENT tm258886d1_8ka_htm.xml XML 3687
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

EIN.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37852 | Film No.: 25728759
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)